3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pheochromocytoma
2
Paraganglioma
2
Neuroendocrine Tumors
2
Meningioma
2
von Hippel-Lindau Disease
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Metastatic Neuroendocrine Prostate Cancer
1
Kidney Neoplasms
1
Hypertension
1
Head and Neck Neoplasms
1
Ganglioneuroma
1
Ganglioneuroblastoma
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
Magnetic Resonance Spectroscopy
22
Temozolomide
17
Specimen Handling
13
X-Rays
9
Biopsy
9
Radiotherapy
8
Radiation
8
trametinib
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Bevacizumab
6
larotrectinib
4
erdafitinib
4
dabrafenib
4
ulixertinib
3
palbociclib
3
abemaciclib
3
Surgical Procedures, Operative
3
Nivolumab
3
Cyclophosphamide
3
vorasidenib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
olaparib
2
mirdametinib
2
lutetium Lu 177 dotatate
2
ivosidenib
2
fluorodopa F 18
2
fludarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
gallium Ga 68 dotatate
×
90 days
×
Clear all
No trials found.